Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
HFA 2017 by PD DR. Christian Veltmann
Author(s): Christian Veltmann Added: 6 years ago
Current treatment strategies for newly diagnosed heart failure patients - Christian Veltmann from Hannover, Germany speaking from HFA 2017. View more

Heart Failure
Interatrial Shunting for Treating Acute and Chronic Left Heart Failure
Author(s): Leonardo Guimaraes , David del Val , Sebastien Bergeron , et al Added: 3 years ago
Major advances in heart failure (HF) management have been achieved over the past three decades, yet it remains a syndrome with high morbidity and mortality, poor quality of life and high healthcare costs. Despite all advances in medical/device therapy, many HF patients continue to deteriorate, leading to poor quality of life and high rehospitalisation and mortality rates.1 The recent European… View more

Vascular Disease and Surgery

Heart Failure
ESC 22: EMPEROR-Preserved & DELIVER Meta-Analysis: SGLT2is in HF
Author(s): Muthiah Vaduganathan Added: 1 year ago
ESC 22 - Dr Muthiah Vaduganathan joins us on-site at ESC 2022 to discuss the findings of a prespecified meta-analysis of the EMPEROR-Preserved and DELIVER Trials, both of which aimed to evaluate the effects of SGLT2 inhibitors on patients with heart failure. Questions: 1. What were the prespecifications for this meta-analysis? 2. What was the rationale for performing a meta-analysis on these… View more

Heart Failure
Author(s): Masaaki Takeuchi , Nobuhiko Haruki , Yutaka Otsuji Added: 3 years ago
More than half of the patients with chronic heart failure (CHF) have associated sleep-disordered breathing (SDB), which consists of either obstructive sleep apnoea (OSA) or central sleep apnoea (CSA).1,2 SDB has deleterious effects on systolic and diastolic ventricular function. In patients with CHF, the presence of SDB results in a poorer prognosis;3,4 thus, its early recognition and adequate… View more

Imaging & Diagnostics

Heart Failure
Ferric Carboxymaltose: Ironing Out the Issues Around HF Related Readmission
Author(s): David Sim , Maurizio Volterrani , Daniel Lighezan , et al Start date: Apr 13, 2022

Heart Failure
New Challenges in the Management of Heart Failure
Author(s): Juan Carlos Kaski , Giuseppe Rosano , Theresa A McDonagh , et al Start date: Nov 05, 2020

Heart Failure
ESC 23: The PUSH-AHF Study
Author(s): Jozine ter Maaten Added: 7 months ago
ESC 2023 — Dr Jozine Ter Maaten (University Medical Centre Groningen, NL) joins us to outline the findings from the PUSH-AHF Study (NCT04606927). PUSH-AHF (University Medical Center Groningen) aimed to assess the effect of natriuresis-guided therapy in patients with acute heart failure to improve diagnostic response, decongestion and clinical outcomes. 310 patients with a primary diagnosis of… View more

Heart Failure
Evaluation of the Effect of Heart Failure Reversal Therapy on Exercise Capacity in Patients with Chronic Heart Failure and the Association with Co-morbidities
Author(s): R Sane Added: 3 years ago
Aims: New treatment modalities are needed to improve the aerobic capacity of patients with chronic heart failure (CHF), considering the increasing disease prevalence. This study was done to evaluate the effect of heart failure reversal therapy (HFRT) on exercise indices, viz.VO2 max and metabolic equivalents (METs). Methodology: This retrospective study screened data of 147 patients who visited… View more

Heart Failure
Risk For Heart Failure Modulate The Effectiveness Of Empagliflozin ? with Javed Butler
Author(s): Javed Butler Added: 6 years ago
This interview with Javed Butler from Stony Brook University, New York, USA discusses Does the Risk for Heart Failure Modulates the Effectiveness of Empagliflozin on Heart Failure Hospitalization or Cardiovascular Death in Patients with Type 2 Diabetes without Heart Failure? Filmed by Radcliffe Cardiology on-site at ESC 2017. View more

Heart Failure

Prevention & Chronic Conditions
Chrysanthemum morifolium Extract Prevents the Development of Doxorubicin-induced Heart Failure
Author(s): Masaya Ono , Yoichi Sunagawa , Yasufumi Katanasaka , et al Added: 2 years ago

CV Disease in Special Populations